TECTONIC THERAPEUTIC INC (TECX) Stock Analyst Earnings Estimates
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| EBITDA YoY % growth | N/A | N/A -70.63% | N/A -79.81% | -117.442M 9.46% | -103.994M 11.45% | -71.05M 31.68% | N/A -11.40% | N/A -29.64% | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A -69.45% | N/A -74.68% | -118.841M 7.20% | -105.434M 11.28% | -71.667M 32.03% | N/A 7.47% | N/A -26.02% | N/A -12.09% | N/A 98.15% | N/A 29.41% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.68 16.63% | -3.31 -23.51% | -2.79 15.71% | -2.41 13.62% | -3.78 -56.85% | N/A -117.96% | N/A 36.65% | N/A -1.42% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.39 42.09% | -1.28 28.74% | -1.29 70.27% | -1.29 -7.53% | -1.36 2.39% | -1.36 -5.77% | -1.40 -8.70% | -1.40 -8.70% | -1.42 -4.51% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.916M -117.26% | -19.942M -53.78% | -20.701M -81.26% | -20.926M -6.56% | -21.801M -4.23% | -20.991M -5.26% | -21.363M -3.20% | -21.742M -3.90% | -22.129M -1.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.20 -172.73% | -0.84 | -0.36 | -42.60% |
| Q2 2024 Q2Q % growth | -4.34 -1,072.97% | -1.53 | -2.81 | -183.66% |
| Q1 2024 Q2Q % growth | -1.80 -215.79% | -4.41 | 2.61 | 59.15% |
| Q4 2023 Q2Q % growth | -2.40 -321.05% | -4.12 | 1.72 | 41.76% |
| Q3 2023 Q2Q % growth | -0.44 15.38% | -0.29 | -0.15 | -52.25% |
| Q2 2023 Q2Q % growth | -0.37 42.19% | -0.08 | -0.29 | -385.28% |
| Q1 2023 Q2Q % growth | -0.57 16.18% | -0.56 | -0.01 | -2.54% |
| Q4 2022 Q2Q % growth | -0.57 12.31% | -0.50 | -0.07 | -13.47% |
| Q3 2022 Q2Q % growth | -0.52 30.67% | -0.56 | 0.04 | 7.31% |
| Q2 2022 Q2Q % growth | -0.64 13.51% | -0.58 | -0.06 | -9.60% |
| Q1 2022 Q2Q % growth | -0.68 -4.62% | -0.60 | -0.08 | -12.57% |
| Q4 2021 Q2Q % growth | -0.65 10.96% | -0.75 | 0.10 | 13.88% |
| Q3 2021 Q2Q % growth | -0.75 25.74% | -0.77 | 0.02 | 2.97% |
| Q2 2021 Q2Q % growth | -0.74 7.50% | -0.68 | -0.06 | -8.12% |
| Q1 2021 Q2Q % growth | -0.65 15.58% | -0.78 | 0.13 | 16.97% |
| Q4 2020 Q2Q % growth | -0.73 -1.39% | -0.92 | 0.19 | 20.48% |
| Q3 2020 Q2Q % growth | -1.01 -77.19% | -0.82 | -0.19 | -23.20% |
| Q2 2020 Q2Q % growth | -0.80 -19.40% | -0.78 | -0.02 | -3.05% |
| Q1 2020 Q2Q % growth | -0.77 -6.94% | -0.68 | -0.09 | -13.01% |
| Q4 2019 Q2Q % growth | -0.72 | -0.61 | -0.11 | -18.84% |
| Q3 2019 Q2Q % growth | -0.57 | -0.60 | 0.03 | 4.89% |
| Q2 2019 Q2Q % growth | -0.67 | -0.78 | 0.11 | 13.57% |
| Q1 2019 Q2Q % growth | -0.72 | -0.73 | 0.01 | 1.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -948.08% | 0% | -64.34% |
| Revenue | N/A | N/A | N/A | N/A |